Combined Ultrasound Guided Bilateral Rectus Sheath and Erector Spinae Plain Blocks Versus Erector Spinae Plain Block for Intra and Postoperative Analgesia in Elective Abdominoplastic Surgeries. a Randomized Controlled Double Blinded Trial.

Launched by CAIRO UNIVERSITY · Jan 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods for managing pain during and after elective abdominoplasty surgeries, which are procedures to reshape the abdominal area. The main question is whether using a combination of two specific types of pain relief techniques—called bilateral rectus sheath and erector spinae plane blocks—works better than just using one of them alone, the erector spinae plane block. The goal is to see if the combined method can help patients feel less pain while using less morphine, a strong pain medication.

To participate in this trial, you need to be between the ages of 21 and 60, and have a specific health status (ASA I or II), which means you're generally healthy or have mild health issues. Unfortunately, if you're outside this age range, have a serious health condition, or are allergic to the medications used in the study, you won't be eligible. If you join the study, you can expect to receive one of the two pain management methods during your surgery and then be monitored for how well it works in reducing pain afterward. The trial aims to improve pain control for patients undergoing these types of surgeries and ensure their recovery is as comfortable as possible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients Age from 21 to 60 years ,Male and female patients ,ASA I, II patients scheduled for elective abdominoplastic surgeries during the study duration.
• Exclusion Criteria:
• • Patient refusal, Age less than 21 and above 60 years old, ASA III, IV patients., Infection at the site of injection, Opioid addiction, Allergy to any used substances (lidocaine, bupivacaine)., Preexisting severe or uncontrolled respiratory, renal or cardiac disease. , INR more than 1.5 and platelets less than 100000.